Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis.
暂无分享,去创建一个
Alain Pitiot | Ludwig Kappos | Christian Enzinger | Massimiliano Calabrese | Xavier Montalban | Reinhold Schmidt | Nikos Evangelou | Friedemann Paul | Àlex Rovira | Jens Wuerfel | À. Rovira | C. Enzinger | X. Montalban | L. Kappos | M. Schoonheim | F. Paul | A. Giorgio | R. Schmidt | J. Wuerfel | N. Evangelou | D. Meier | M. Calabrese | A. Pitiot | M. Pawlak | T. Sinnecker | Menno M Schoonheim | Nicola De Stefano | Tim Sinnecker | M. Clarke | Antonio Giorgio | Margareta A Clarke | Dominik Meier | Mikolaj A Pawlak | N. de Stefano | R. Schmidt | R. Schmidt
[1] A. Cross,et al. Misdiagnosis of multiple sclerosis , 2018, Neurology.
[2] Pascal Sati,et al. FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins. , 2012, Radiology.
[3] A. Traboulsee,et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2015, Neurology.
[4] David H. Miller,et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.
[5] O. Ciccarelli,et al. MRI CRITERIA FOR THE DIAGNOSIS OF MULTIPLE SCLEROSIS: MAGNIMS CONSENSUS GUIDELINES , 2016, The Lancet Neurology.
[6] D. Reich,et al. “Central vessel sign” on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine , 2015, Annals of clinical and translational neurology.
[7] P. Trillenberg,et al. Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[8] Suk-Won Ahn,et al. Application of the 2017 McDonald diagnostic criteria for multiple sclerosis in Korean patients with clinically isolated syndrome , 2018, Multiple sclerosis.
[9] V. Tomassini,et al. Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis , 2018, Multiple sclerosis.
[10] F. Paul,et al. Identical lesion morphology in primary progressive and relapsing–remitting MS –an ultrahigh field MRI study , 2014, Multiple sclerosis.
[11] Massimo Filippi,et al. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies , 2018, Annals of neurology.
[12] Su-Hyun Kim,et al. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders , 2014, Multiple sclerosis.
[13] M E Miquel,et al. FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis? , 2017, European Radiology.
[14] D. Reich,et al. Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis , 2016, Multiple sclerosis.
[15] M. Midiri,et al. Multiple sclerosis: High prevalence of the ‘central vein’ sign in white matter lesions on susceptibility-weighted images , 2018, The neuroradiology journal.
[16] D. Reich,et al. Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis , 2014, Multiple sclerosis.
[17] C. Catsman-Berrevoets,et al. Real-world validation of the 2017 McDonald criteria for pediatric MS , 2018, Neurology: Neuroimmunology & Neuroinflammation.
[18] S. Ourselin,et al. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD , 2018, Neurology.
[19] P. Morgan,et al. Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions , 2016, Multiple sclerosis.
[20] J. Simon,et al. Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients , 2013, Multiple sclerosis.
[21] Nikos Evangelou,et al. A Comparison of 3T and 7T in the Detection of Small Parenchymal Veins Within MS Lesions , 2009, Investigative radiology.
[22] M. Schlamann,et al. First Clinical Study on Ultra-High-Field MR Imaging in Patients with Multiple Sclerosis: Comparison of 1.5T and 7T , 2009, American Journal of Neuroradiology.
[23] K. Šurlan Popovič,et al. Presence of central veins and susceptibility weighted imaging for evaluating lesions in multiple sclerosis and leukoaraiosis. , 2017, Multiple sclerosis and related disorders.
[24] E. Ringelstein,et al. Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis , 2012, Multiple sclerosis.
[25] M. Benedetti,et al. 2017 McDonald criteria for multiple sclerosis: Earlier diagnosis with reduced specificity? , 2019, Multiple sclerosis and related disorders.
[26] Pascal Sati,et al. Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm , 2018, Multiple sclerosis.
[27] F. Barkhof,et al. The 11-year long-term follow-up study from the randomized BENEFIT CIS trial , 2016, Neurology.
[28] Jeffrey A. Cohen,et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.
[29] M. Habek,et al. Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria. , 2018, Multiple sclerosis and related disorders.
[30] Ludwig Kappos,et al. The current role of MRI in differentiating multiple sclerosis from its imaging mimics , 2018, Nature Reviews Neurology.
[31] C. Pfueller,et al. Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis , 2012, Neurology.
[32] Nikos Evangelou,et al. The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T , 2017, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[33] P. Calabresi,et al. 2017 revisions of McDonald criteria shorten the time to diagnosis of multiple sclerosis in clinically isolated syndromes , 2018, Journal of Neurology.
[34] R. Hintzen,et al. Application of the 2017 Revised McDonald Criteria for Multiple Sclerosis to Patients With a Typical Clinically Isolated Syndrome , 2018, JAMA neurology.
[35] Roland G. Henry,et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative , 2016, Nature Reviews Neurology.
[36] W. Johnson,et al. Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren’s syndrome , 2014, Multiple sclerosis.
[37] P S Morgan,et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions , 2011, Neurology.